Tag: Multiple Sclerosis
MS Relapse Risk Not Increased in Postoperative Period
Odds of postoperative versus preoperative relapse were not increased in unadjusted, adjusted analyses
Obesity Linked to Increased Risk for Pediatric Multiple Sclerosis
Obese patients have significantly more relapses on first-line treatment with IFN beta, glatiramer acetate
Standing Frame Program Can Up Motor Function in Progressive MS
Motor function increased significantly but not to degree considered a priori as clinically meaningful
Increased Cancer Risk Seen in Multiple Sclerosis Patients
Cancer risk up for MS patients versus non-MS controls, especially in respiratory, urinary, CNS organs
Cognitive Consequences Worse for Pediatric-Onset Multiple Sclerosis
Patients with POMS have more rapid reduction in information-processing efficiency over time
Model Explores How Statins Alter Multiple Sclerosis Outcomes
Loss of brain volume reduced in patients taking simvastatin independent of effect on cholesterol level
Recommendations Developed for Pediatric Multiple Sclerosis Trials
Biological rationale exists for using treatments proven efficacious in adults with MS for pediatric MS
Thresholds Found for Unilateral Optic Nerve Lesions in MS
Intereye differences for retinal nerve fiber layer and macular ganglion cell + inner plexiform layer useful
AAN: Oral BTK Inhibitor Superior to Placebo in Multiple Sclerosis
Fewer enhancing lesions seen in weeks 12 to 24 for 75 mg evobrutinib once daily versus placebo
Significant Number of Referred Patients Misdiagnosed With MS
At MS referral centers, almost one in five new patients have been incorrectly diagnosed with the disease
